12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Company News  |  Deals

Tissue Regenix, NHS Blood and Transplant deal

Tissue Regenix amended a deal with NHS Blood and Transport (NHSBT) in order to expand the scope of clinical development activities for Tissue Regenix's dCELL technology. Under the original deal, NHSBT has the right to conduct preclinical and clinical evaluation using...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >